Real-Life Efficacy and Safety of Glecaprevir/Pibrentasvir Pediatric Formulation for Chronic Hepatitis C Infection in Children Aged 3 to 12 Years: A Case Series of 6 Patients

•Optimal real-life efficacy of glecaprevir/pibrentasvir pediatric formulation for chronic Hepatitis C infection in children aged 3 to 12 years.•Real-life palatability and compliance of glecaprevir/pibrentasvir pediatric formulation.•Good safety of glecaprevir/pibrentasvir pediatric formulation.•Cons...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical therapeutics Vol. 47; no. 3; pp. 244 - 247
Main Authors:	Musto, Francesca, Stracuzzi, Marta, Cibarelli, Alessandro, Coppola, Crescenzo, Caiazzo, Roberta, David, Daniela, Di Tonno, Raffaella, Garcia, Marc Lorenzo, Valentino, Maria Sole, Giacomet, Vania
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01.03.2025 Elsevier Limited
Subjects:	Adverse events Aminoisobutyric Acids Antiviral Agents - administration & dosage Antiviral Agents - adverse effects Antiviral Agents - therapeutic use Antiviral drugs Benzimidazoles - administration & dosage Benzimidazoles - adverse effects Benzimidazoles - therapeutic use Child Child, Preschool Childhood Children Children & youth Childrens health Chronic hepatitis C Chronic infection Cyclopropanes Drug Combinations Drug dosages Female Gastroenterology Genotype Genotype & phenotype Genotypes Glecaprevir/pibrentasvir Hepacivirus - drug effects Hepacivirus - genetics Hepatitis C Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - virology Hepatology Humans Infections Internal Medicine Lactams, Macrocyclic Leucine - analogs & derivatives Male Nutrition Patients Pediatric population Pediatrics Proline - analogs & derivatives Pyrrolidines - administration & dosage Pyrrolidines - adverse effects Quinoxalines - administration & dosage Quinoxalines - adverse effects Quinoxalines - therapeutic use Sulfonamides - administration & dosage Sulfonamides - adverse effects Sustained Virologic Response Teenagers Therapy Treatment Outcome Viral Load - drug effects United States > US Italy Therapy Glecaprevir/pibrentasvir Chronic hepatitis C Pediatric population
ISSN:	0149-2918, 1879-114X, 1879-114X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!